3Mameros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids [ J ]. Arch Dermato1,2001,137 ( 11 ) : 1429-1434.
4Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarfing: transforming growth factor betal common polymorphisms and plasma levels [ J ]. Plast Reconstr Surg, 2003,111 (2) :535-543.
5Mameros AG, Norris JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11 [ J ]. J Invest Dermatol,2004,122 (5) : 1126-1132.
6HartyM, Neff AW, King MW, et al. Regenerati on orScarring: an i mmunol ogic PersPective[ J]. Dev Dyn,2003,226(3 ) :268-272.
7Niessin FB,Schalkwijd J,Vos H,et al. Hypertrophic Scar For mati on is ass ociated with an incveased number of epidevmal langerhans cells [ J ]. Pathol,2004,202 ( 1 ) : 121-124.
8Nirodi CS, Devalaraja R, Nanney LB. Chemokine and chemokine receptor expression in keloid and normal fibroblasts [ J ]. Wound Repair Regen ,2000,8 (5) :371-382.
9Boyce DE, Ciampolini J, Ruge F, et al. Inflammatory-cell subpopulations in keldid scars[J]. Br J Plast Surg,2001,54(6) :511-516.
10Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling[ J]. Cardiovasc Res,2007, 74(2) :184-195.
